Addus HomeCare Co. (NASDAQ:ADUS) EVP Sells $25,200.21 in Stock

Addus HomeCare Co. (NASDAQ:ADUS) EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Roberton James Stevenson also recently made the following trade(s):

• On Monday, April 1st, Roberton James Stevenson sold 109 shares of Addus HomeCare stock. The shares were sold at an average price of $103.93, for a total value of $11,328.37.

Addus HomeCare Stock Up 1.4 %

Shares of ADUS stock traded up $1.69 during trading hours on Tuesday, reaching $119.39. 87,402 shares of the company’s stock were exchanged, compared to its average volume of 120,346. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $119.98. The stock has a market cap of $1.95 billion, a PE ratio of 29.42, a PEG ratio of 2.22 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The stock’s fifty day moving average price is $105.98 and its two-hundred day moving average price is $98.31.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The company had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same period in the previous year, the company posted $0.84 earnings per share. Addus HomeCare’s revenue for the quarter was up 11.6% on a year-over-year basis. Research analysts predict that Addus HomeCare Co. will post 4.36 EPS for the current year.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several research reports. StockNews.com upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 6th. TD Cowen raised their price target on Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday. Stephens lifted their target price on Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. Oppenheimer lifted their target price on Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. Finally, Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a research note on Tuesday, April 23rd. One investment analyst has rated the stock with a sell rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $113.43.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Boston Partners purchased a new stake in shares of Addus HomeCare in the first quarter valued at approximately $12,215,000. Hancock Whitney Corp increased its position in shares of Addus HomeCare by 5.4% in the first quarter. Hancock Whitney Corp now owns 5,102 shares of the company’s stock valued at $527,000 after buying an additional 263 shares in the last quarter. Janus Henderson Group PLC increased its position in shares of Addus HomeCare by 683.7% in the first quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock valued at $5,703,000 after buying an additional 48,146 shares in the last quarter. Lazard Asset Management LLC increased its position in shares of Addus HomeCare by 11.9% in the first quarter. Lazard Asset Management LLC now owns 5,128 shares of the company’s stock valued at $529,000 after buying an additional 547 shares in the last quarter. Finally, Quadrature Capital Ltd purchased a new stake in shares of Addus HomeCare in the first quarter valued at approximately $1,557,000. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.